Serum level of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in acute coronary syndromes and relationship with prognosis; [Akut Koroner Sendromlarda ̇ Insl̈in Benzeri Büyüme Faktörü-I ve ̇ Insülin Benzeri Büyüme Faktörü Baǧlayici Protein-3 Düzeyleri ve Prognozla ̇ Ilişkisi]
No Thumbnail Available
Date
2004
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Objective: The aim of the present study was to examine the levels of insulin-like growth factor (IGF-I) and binding protein-3 (IGFBP-3) in acute coronary syndrome (ACS) and their relationship with prognosis. Methods: Thirty patients with ACS (22 male, 8 female) were included in our study. Patient's population included 20 patients with ST elevation myocardial infarction (STEMI) and 10 with non-ST-elevation ACS. Death, re-infarction, revascularization and malignant arrhythmia were monitored during 3 months. Study group was compared with 20 healthy subjects (Controls). Blood samples were collected in the first 24 hours and at the end of third month. Serum IGF-I and IGFBP-3 levels were determined by radioimmunoassay method. Results: We found decreased level of IGF-I only in the STEMI group (105±84 ng/ml vs. 715±150 ng/ml, p<0.0001). There were no significant differences in IGFBP-3 levels between two groups. Serum IGF-I levels were significantly increased after 3rd month in the STEMI group (356±72 ng/ml vs. 105±84 ng/ml, p=0.025). There was no relationship between IGF-I, IGFBP-3 levels and cardiovascular events occurred during 90 days of follow-up. Conclusion: These data allows to suggest that significantly decreased level of IGF-I in STEMI group of ACSs can be used as a marker of myocardial necrosis. There was no relationship between IGF-I level and cardiovascular events occurred in 90 days, so this parameter can not be used as a negative prognostic factor.
Description
Keywords
Case-Control Studies , Cholesterol , Cholesterol, HDL , Cholesterol, LDL , Female , Humans , Insulin-Like Growth Factor Binding Protein 3 , Insulin-Like Growth Factor I , Male , Middle Aged , Myocardial Infarction , Prognosis , Severity of Illness Index , Triglycerides , Turkey , somatomedin binding protein 3 , somatomedin C , cholesterol , high density lipoprotein cholesterol , low density lipoprotein cholesterol , somatomedin binding protein 3 , somatomedin C , triacylglycerol , adult , aged , article , blood analysis , clinical article , comparative study , controlled study , death , disease marker , female , follow up , heart arrhythmia , heart infarction , heart muscle ischemia , heart muscle necrosis , heart reinfarction , human , male , patient monitoring , population research , prognosis , protein blood level , radioimmunoassay , revascularization , ST segment elevation , statistical significance , blood , case control study , heart infarction , hospitalization , metabolism , middle aged , mortality , Turkey (republic)